Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Capsule endoscopy visualizes recurrences of Crohn’s disease

Oct 2007
Capsule endoscopy has been shown to be more effective than colonoscopy in diagnosing the recurrence of Crohn’s disease after surgery. At La Fe University Hospital in Valencia, Spain, investigators conducted a study on 24 patients with Crohn’s disease who had undergone resection, the removal of the diseased section of the intestine, and anastomosis, the joining together of the remaining healthy section.

They found that capsule endoscopy can identify disease recurrence in 62 percent of patients, whereas colonoscopy identified evidence of the disease in only 25 percent. The main objective of the study was to evaluate capsule endoscopy in terms of safety, accuracy and therapeutic effect. The research is detailed in the September issue of Gastrointestinal Endoscopy.

Because there is no known cause or cure for Crohn’s disease, the treatment goal is to reduce the inflammation. When medication no longer controls the symptoms, surgery is performed, but recurrence frequently follows it.

Capsule endoscopy allows physicians to view the lining of the middle section of the gastrointestinal (GI) tract, including the three portions of the small intestine — the duodenum, jejunum and ileum — but the method is not used to view the large intestine. A patient swallows a pill that contains a tiny camera, which captures images of the GI tract and transmits them to a computer for diagnostic viewing.

Colonoscopy, the standard tool used in screening for colon cancer, effectively diagnoses diseases in the large intestine; however, although it enables the closer sections of the small intestine to be viewed, it is not designed to reach the most distant portions.

All 24 subjects underwent a colonoscopy, and 22 of them, capsule endoscopy using the M2A Capsule System from Given Imaging Ltd. of Yokneam, Israel, to assess the disease at the site of the anastomosis and in the remaining small intestine. Colonoscopy did not reach the end part of the small intestine in three of the patients. All subjects were asymptomatic and were not receiving treatment for the disease.

Colonoscopy detected recurring disease in the remaining end of the small intestine in six patients. Capsule endoscopy identified five of these six patients and another 10 patients with recurrence higher up in the small intestine. These findings resulted in the decision to modify therapy in 13 patients. Colonoscopy alone would have led to altered treatment in six patients, while capsule endoscopy alone provided data in the seven remaining patients.

The researchers concluded that capsule endoscopy is an important tool for visualizing the small intestine, which is inaccessible by colonoscopy, and that both methods are complementary in the diagnosis and treatment of diseases in the gastrointestinal tract. Also, patients noted during the study that they were more comfortable with the capsule endoscopy method.

As We Go To PressBiophotonicsBreaking Newscamerascapsule endoscopyCrohn’s diseasePresstime Bulletin

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.